LRRC15⁺ Myofibroblasts Dictate the Stromal Setpoint To Suppress Tumor Immunity

In mouse models of pancreatic cancer, scientists provide in vivo genetic evidence that TGFβ receptor type 2 signaling in healthy dermatopontin+ universal fibroblasts is essential for the development of cancer-associated LRRC15+ myofibroblasts.